New and returning investors participated in the Kaplan-backed educational content provider’s latest round, which boosted its overall funding to $170m.

Returning corporate investors Takeda Ventures and MRL Ventures Fund helped the cancer immunotherapy developer take its total funding to over $225m.

GC and its GC LabCell subsidiary both contributed to a round that will help advance the cancer immunotherapy developer's NK cell drug pipeline.

Experian helped the mobile payment services provider pass $100m of total funding, participating in a round that will support hiring and product development.

The Hakuhodo DY, Ricoh Leasing and Orix-backed B2C e-commerce payment service has received $56.4m from JCB at a $551m valuation.

Koch Disruptive Technologies led a series C round for the data storage technology producer that included Western Digital, SoftBank, Xilinx, Nvidia and Intel.

The KingMed Diagnostics and WuXi AppTec-backed cancer diagnosis technology developer intends to use the series C funding to bring its products to market.

Estée Lauder Companies has hiked its stake in the skincare product maker to a majority share, having first invested four years ago.

Prosus contributed to a series D round that allowed the coding education provider increase its overall funding to more than $82m.

The Gunderson Dettmer, Anchor Worldwide and Slack-backed IT management platform developer boosted its total funding to $100m through its series C round.